Marquette Asset Management, LLC Galecto, Inc. Transaction History

Marquette Asset Management, LLC

  • $629 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022
BUY
$1.22 - $2.74 $17,664 - $39,672
14,479 Added 31.64%
60,244 $104,000
Q1 2022

Apr 26, 2022
BUY
$1.72 - $3.31 $15,935 - $30,667
9,265 Added 25.38%
45,765 $101,000
Q4 2021

Jan 19, 2022
BUY
$2.3 - $3.58 $28,439 - $44,266
12,365 Added 51.23%
36,500 $111,000
Q3 2021

Oct 12, 2021
BUY
$3.59 - $5.0 $86,644 - $120,675
24,135 New
24,135 $87,000

Others Institutions Holding GLTO

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Galecto, Inc.

GLTO Quotes by TradingView
  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $131M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email